{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:16:10Z","timestamp":1787771770293,"version":"build-2784847793"},"reference-count":181,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol India"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/0028-3886.246258","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T05:16:30Z","timestamp":1550466990000},"page":"1732","source":"Crossref","is-referenced-by-count":39,"title":["Neurotoxicity of the antibiotics: A comprehensive study"],"prefix":"10.4103","volume":"66","author":[{"given":"SeyedAhmad","family":"Naseri Alavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NaghmehJavanshir","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AmirMohammad","family":"Bazzazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0028-3886.246258-1","first-page":"448","volume-title":"Antibiotic-induced neurotoxicity","author":"Bhattacharyya","year":"2014","journal-title":"Curr Infect Dis Rep"},{"key":"key-10.4103\/0028-3886.246258-2","unstructured":"Ashwin Kamath; Fluoroquinolone induced neurotoxicity: A review. J Adv Pharm Edu Res 2013;3:72-5."},{"key":"key-10.4103\/0028-3886.246258-3","first-page":"869","volume-title":"Neurotoxicity of antibacterial therapy","author":"Thomas","year":"1994","journal-title":"South Med J"},{"key":"key-10.4103\/0028-3886.246258-4","first-page":"381","volume-title":"Neurotoxic effects associated with antibiotic use: Management considerations","author":"Grill","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"key-10.4103\/0028-3886.246258-5","first-page":"649","volume-title":"Neurotoxicity induced by beta-lactam antibiotics: From bench to bedside","author":"Chow","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key-10.4103\/0028-3886.246258-6","first-page":"275","volume-title":"Tardive seizure and antibiotics: Case reports and review of the literature","author":"Saito","year":"2008","journal-title":"JECT"},{"key":"key-10.4103\/0028-3886.246258-7","first-page":"149","volume-title":"Neurotoxicity and CSF level of three penicillins","author":"Kolb","year":"1976","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"key-10.4103\/0028-3886.246258-8","first-page":"47","volume-title":"Neurotoxicity and \u201cmassive\u201d intravenous therapy with penicillin.A study of possible predisposing factors","author":"Smith","year":"1967","journal-title":"Arch Intern Med"},{"key":"key-10.4103\/0028-3886.246258-9","first-page":"369","volume-title":"Retrospective review of neurotoxicity induced by cefepime and ceftazidime","author":"Chow","year":"2003","journal-title":"Pharmacotherapy"},{"key":"key-10.4103\/0028-3886.246258-10","doi-asserted-by":"crossref","unstructured":"Penicillin, ceftazidime, and the epilepsies. Lancet 1992;340:400-1.","DOI":"10.1016\/0140-6736(92)91476-O"},{"key":"key-10.4103\/0028-3886.246258-11","first-page":"692","volume-title":"Penicillin convulsions; The convulsive effects of penicillin applied to the cerebral cortex of monkey and man","author":"Walker","year":"1945","journal-title":"Surg Gynecol Obstet"},{"key":"key-10.4103\/0028-3886.246258-12","first-page":"87","volume-title":"The absorption into and distribution of penicillin in the cerebrospinal fluid","author":"Dumoff-Stanley","year":"1946","journal-title":"J Clin Invest"},{"key":"key-10.4103\/0028-3886.246258-13","first-page":"181","volume-title":"Piperacillin\/tazobactam-induced seizure rapidly reversed by high flux hemodialysis in a patient on peritoneal dialysis","author":"Lin","year":"2007","journal-title":"Am J Med Sci"},{"key":"key-10.4103\/0028-3886.246258-14","first-page":"374","volume-title":"Neurotoxicity associated with standard doses of piperacillin in an elderly patient with renal failure","author":"Huang","year":"2009","journal-title":"Infection"},{"key":"key-10.4103\/0028-3886.246258-15","first-page":"482","volume-title":"Ampicillin-induced neurotoxicity in very-low-birth-weight neonates","author":"Shaffer","year":"1998","journal-title":"Ann Pharmacother"},{"key":"key-10.4103\/0028-3886.246258-16","first-page":"405","volume-title":"Neurotoxicity of beta-lactam antibiotics: Predisposing factors and pathogenesis","author":"Schliamser","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0028-3886.246258-17","first-page":"16747","volume-title":"Gamma-aminobutyric acid A receptor structure and function","author":"DeLorey","year":"1992","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0028-3886.246258-18","first-page":"427","volume-title":"The beta-lactam antibiotics, penicillin-G and cefoselis have different mechanisms and sites of action at GABA(A) receptors","author":"Sugimoto","year":"2002","journal-title":"Br J Pharmacol"},{"key":"key-10.4103\/0028-3886.246258-19","first-page":"23","volume-title":"Penicillin blocks human alpha 1 beta 1 and alpha 1 beta 1 gamma 2S GABAA channels that open spontaneously","author":"Lindquist","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"key-10.4103\/0028-3886.246258-20","first-page":"304","volume-title":"Evidence for the involvement of GABA(A) receptor blockade in convulsions induced by cephalosporins","author":"Sugimoto","year":"2003","journal-title":"Neuropharmacology"},{"key":"key-10.4103\/0028-3886.246258-21","first-page":"938","volume-title":"Epileptogenic effect of antibiotic drugs","author":"Grondahl","year":"1993","journal-title":"J Neurosurg"},{"key":"key-10.4103\/0028-3886.246258-22","first-page":"759","volume-title":"Penicillinase and the convulsant action of penicillin","author":"Gutnick","year":"1971","journal-title":"Neurology"},{"key":"key-10.4103\/0028-3886.246258-23","first-page":"571","volume-title":"Epileptogenic action of penicillin derivatives: Structure-activity relationship","author":"Esplin","year":"1985","journal-title":"Neuropharmacology"},{"key":"key-10.4103\/0028-3886.246258-24","first-page":"359","volume-title":"Epileptogenic activity of some beta-lactam derivatives: Structure-activity relationship","author":"De","year":"1989","journal-title":"Neuropharmacology"},{"key":"key-10.4103\/0028-3886.246258-25","first-page":"80","volume-title":"How epileptogenic are the recent antibiotics?","author":"Hantson","year":"1999","journal-title":"Acta Clin Belg"},{"key":"key-10.4103\/0028-3886.246258-26","first-page":"356","volume-title":"High doses of penicillin decreases [3H]flunitrazepam binding sites in rat neuron primary culture","author":"Shiraishi","year":"1993","journal-title":"Brain Dev"},{"key":"key-10.4103\/0028-3886.246258-27","first-page":"214","volume-title":"Cefepime-induced neurotoxicity: An underestimated complication of antibiotherapy in patients with acute renal failure","author":"Chatellier","year":"2002","journal-title":"Intensive Care Med"},{"key":"key-10.4103\/0028-3886.246258-28","first-page":"1843","volume-title":"Cephalosporin-induced neurotoxicity: Clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring","author":"Grill","year":"2008","journal-title":"Ann Pharmacother"},{"key":"key-10.4103\/0028-3886.246258-29","first-page":"966","volume-title":"The neurotoxicity and safety of treatment with cefepime in patients with renal failure","author":"Sonck","year":"2008","journal-title":"Nephrol Dail Transplant"},{"key":"key-10.4103\/0028-3886.246258-30","first-page":"1011","volume-title":"Severe neurotoxicity of cefepime in uremic patients","author":"Barbey","year":"2001","journal-title":"Annals Intern Med"},{"key":"key-10.4103\/0028-3886.246258-31","first-page":"87","volume-title":"Cefepime-induced encephalopathy: Clinical and electroencephalographic features in seven patients","author":"Bragatti","year":"2005","journal-title":"Arq Neuropsiquiatr"},{"key":"key-10.4103\/0028-3886.246258-32","first-page":"450","volume-title":"Cefepime-induced encephalopathy with triphasic waves in three Asian patients","author":"De","year":"2007","journal-title":"Ann Acad Med Singapore"},{"key":"key-10.4103\/0028-3886.246258-33","first-page":"1840","volume-title":"Cefepime- and cefixime-induced encephalopathy in a patient with normal renal function","author":"Capparelli","year":"2005","journal-title":"Neurology"},{"key":"key-10.4103\/0028-3886.246258-34","first-page":"72","volume-title":"Ceftriaxone-induced acute reversible encephalopathy in a patient treated for a urinary tract infection","author":"Roncon-Albuquerque","year":"2009","journal-title":"Neth J Med"},{"key":"key-10.4103\/0028-3886.246258-35","first-page":"386","volume-title":"High imipenem blood concentrations associated with toxic encephalopathy in a patient with mild renal dysfunction","author":"Lamoth","year":"2009","journal-title":"International J Antimicrob Agents"},{"key":"key-10.4103\/0028-3886.246258-36","first-page":"352","volume-title":"Ertapenem-associated seizures in a peritoneal dialysis patient","author":"Seto","year":"2005","journal-title":"Ann Pharmacother"},{"key":"key-10.4103\/0028-3886.246258-37","first-page":"122","volume-title":"Imipenem\/cilastatin treatment of bacterial meningitis in children","author":"Wong","year":"1991","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.4103\/0028-3886.246258-38","first-page":"743","volume-title":"Newer beta-lactam antibiotics: Doripenem, ceftobiprole, ceftaroline, and cefepime","author":"Bazan","year":"2011","journal-title":"Med Clin North Am"},{"key":"key-10.4103\/0028-3886.246258-39","first-page":"983","volume-title":"Newer beta-lactam antibiotics: Doripenem, ceftobiprole, ceftaroline, and cefepime","author":"Bazan","year":"2009","journal-title":"Infect Dis Clin North Am"},{"key":"key-10.4103\/0028-3886.246258-40","first-page":"87","volume-title":"Neurotoxicity of carbapenem antibacterials","author":"Norrby","year":"1996","journal-title":"Drug Saf"},{"key":"key-10.4103\/0028-3886.246258-41","first-page":"911","volume-title":"Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: Experience with imipenem\/cilastatin","author":"Calandra","year":"1988","journal-title":"Am J Med"},{"key":"key-10.4103\/0028-3886.246258-42","first-page":"1590","volume-title":"Seizures in the critically ill: The role of imipenem","author":"Koppel","year":"2001","journal-title":"Epilepsia"},{"key":"key-10.4103\/0028-3886.246258-43","first-page":"92","volume-title":"The neurotoxicity of antibacterial agents","author":"Snavely","year":"1984","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/0028-3886.246258-44","first-page":"408","volume-title":"Structural features resulting in convulsive activity of carbapenem compounds: Effect of C-2 side chain","author":"Sunagawa","year":"1995","journal-title":"J Antibiot"},{"key":"key-10.4103\/0028-3886.246258-45","first-page":"265","volume-title":"The disposition and metabolism of meropenem in laboratory animals and man","author":"Harrison","year":"1989","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0028-3886.246258-46","first-page":"979","volume-title":"Transport of imipenem, a novel carbapenem antibiotic, in the rat central nervous system","author":"Suzuki","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"key-10.4103\/0028-3886.246258-47","first-page":"292","volume-title":"Comparative convulsant potencies of two carbapenem derivatives in C57 and DBA\/2 mice","author":"de","year":"1995","journal-title":"J Pharm Pharmacol"},{"key":"key-10.4103\/0028-3886.246258-48","first-page":"687","volume-title":"Comparative neurotoxicity of benzylpenicillin, imipenem\/cilastatin and FCE 22101, a new injectible penem","author":"Schliamser","year":"1988","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0028-3886.246258-49","first-page":"3","volume-title":"Safety profile of meropenem: A review of nearly 5,000 patients treated with meropenem","author":"Norrby","year":"1999","journal-title":"Scandi J Infect Dis"},{"key":"key-10.4103\/0028-3886.246258-50","first-page":"5","volume-title":"Neurotoxicity of carbapenem antibiotics: Consequences for their use in bacterial meningitis","author":"Norrby","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0028-3886.246258-51","first-page":"3","volume-title":"Gentamicin neurotoxicity (polyneuropathy-encephalopathy)","author":"Bischoff","year":"1977","journal-title":"Schweiz Med Wochenschr"},{"key":"key-10.4103\/0028-3886.246258-52","doi-asserted-by":"crossref","unstructured":"Watanabe I, Hodges GR, Dworzack DL, Kepes JJ, Duensing GF. Neurotoxicity of intrathecal gentamicin: A case report and experimental study. Ann Neurol 1978;4:564-72.","DOI":"10.1002\/ana.410040618"},{"key":"key-10.4103\/0028-3886.246258-53","first-page":"219","volume-title":"A possible hazard of prolonged neuromuscular blockade by amikacin","author":"Hashimoto","year":"1978","journal-title":"Anesthesiology"},{"key":"key-10.4103\/0028-3886.246258-54","first-page":"552","volume-title":"Tobramycin and neuromuscular blockade","author":"Boliston","year":"1978","journal-title":"Anaesthesia"},{"key":"key-10.4103\/0028-3886.246258-55","first-page":"45","volume-title":"Neuromuscular blocking activity of aminoglycoside antibiotics","author":"Paradelis","year":"1980","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"key-10.4103\/0028-3886.246258-56","first-page":"270","volume-title":"Aminoglycoside neurotoxicity involves NMDA receptor activation","author":"Segal","year":"1999","journal-title":"Brain Res"},{"key":"key-10.4103\/0028-3886.246258-57","first-page":"841","volume-title":"Vestibulotoxicity following aminoglycoside antibiotics and its prevention","author":"Darlington","year":"2003","journal-title":"Curr Opin Investig Drugs"},{"key":"key-10.4103\/0028-3886.246258-58","unstructured":"Fiekers JF. Effects of the aminoglycoside antibiotics, streptomycin and neomycin, on neuromuscular transmission. II. Postsynaptic considerations. J Pharmacol Exp Ther 1983;225:496-502."},{"key":"key-10.4103\/0028-3886.246258-59","first-page":"583","volume-title":"Neurotoxic aminoglycoside antibiotics are potent inhibitors of [125I]-Omega-Conotoxin GVIA binding to guinea-pig cerebral cortex membranes","author":"Knaus","year":"1987","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"key-10.4103\/0028-3886.246258-60","first-page":"S113","volume-title":"The quinolones: Past, present, and future","author":"Andriole","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0028-3886.246258-61","first-page":"255","volume-title":"Classification of fluoroquinolones","author":"Naber","year":"1998","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.4103\/0028-3886.246258-62","first-page":"96","volume-title":"Clinical pharmacokinetics of the newer antibacterial 4-quinolones","author":"Neuman","year":"1988","journal-title":"Clin Pharmacokinet"},{"key":"key-10.4103\/0028-3886.246258-63","first-page":"S144","volume-title":"Antimicrobial safety: Focus on fluoroquinolones","author":"Owens","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0028-3886.246258-64","first-page":"63","volume-title":"Possible interaction of fluoroquinolones with the benzodiazepine- GABAA-receptor complex","author":"Unseld","year":"1990","journal-title":"Br J Clin Pharmacol"},{"key":"key-10.4103\/0028-3886.246258-65","first-page":"614","volume-title":"Levofloxacin-induced delirium: Diagnostic considerations","author":"Fernandez-Torre","year":"2006","journal-title":"Clin Neurol Neurosurg"},{"key":"key-10.4103\/0028-3886.246258-66","first-page":"158","volume-title":"Levofloxacin-induced delirium","author":"Hakko","year":"2005","journal-title":"Clin Neurol Neurosurg"},{"key":"key-10.4103\/0028-3886.246258-67","first-page":"1194","volume-title":"Seizures associated with fluoroquinolones","author":"Kushner","year":"2001","journal-title":"The Ann Pharmacother"},{"key":"key-10.4103\/0028-3886.246258-68","first-page":"731","volume-title":"Reversible orofacial dyskinesia after ofloxacin treatment","author":"De","year":"2004","journal-title":"Mov Disord"},{"key":"key-10.4103\/0028-3886.246258-69","first-page":"553","volume-title":"Case report: Severe neurologic reaction to ciprofloxacin","author":"MacLeod","year":"2001","journal-title":"Can Fam Physician"},{"key":"key-10.4103\/0028-3886.246258-70","doi-asserted-by":"crossref","unstructured":"Ball P, Mandell L, Patou G, Dankner W, Tillotson G. A new respiratory fluoroquinolone, oral gemifloxacin: A safety profile in context. Int J Antimicrob Agents 2004;23:421-9.","DOI":"10.1016\/j.ijantimicag.2004.02.014"},{"key":"key-10.4103\/0028-3886.246258-71","first-page":"269","volume-title":"Clinical toxicological aspects of fluoroquinolones","author":"Stahlmann","year":"2002","journal-title":"Toxicol Lett"},{"key":"key-10.4103\/0028-3886.246258-72","first-page":"193","volume-title":"Safety considerations of fluoroquinolones in the elderly: An update","author":"Stahlmann","year":"2010","journal-title":"Drugs Aging"},{"key":"key-10.4103\/0028-3886.246258-73","first-page":"616","volume-title":"Reversible oral-facial dyskinesia in a patient receiving ciprofloxacin hydrochloride","author":"Pastor","year":"1996","journal-title":"J Neurol"},{"key":"key-10.4103\/0028-3886.246258-74","first-page":"138","volume-title":"Potential neurologic toxicity related to ciprofloxacin","author":"Schwartz","year":"1990","journal-title":"DICP"},{"key":"key-10.4103\/0028-3886.246258-75","first-page":"1283","volume-title":"Fluoroquinolone associated myasthenia gravis exacerbation: Clinical analysis of 9 cases","author":"Wang","year":"2013","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"key-10.4103\/0028-3886.246258-76","first-page":"1778","volume-title":"Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin","author":"Bowie","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0028-3886.246258-77","first-page":"412","volume-title":"Levofloxacin, an optical isomer of ofloxacin, has attenuated epileptogenic activity in mice and inhibitory potency in GABA receptor binding","author":"Akahane","year":"1994","journal-title":"Chemotherapy"},{"key":"key-10.4103\/0028-3886.246258-78","first-page":"1704","volume-title":"Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites","author":"Akahane","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0028-3886.246258-79","first-page":"1","volume-title":"Toxicity of quinolone antimicrobial agents","author":"Takayama","year":"1995","journal-title":"J Toxicol Environ Health"},{"key":"key-10.4103\/0028-3886.246258-80","first-page":"1831","volume-title":"Determination of the excitatory potencies of fluoroquinolones in the central nervous system by an in vitro model","author":"Schmuck","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0028-3886.246258-81","first-page":"685","volume-title":"Structure-activity and structure-side-effect relationships for the quinolone antibacterials","author":"Domagala","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0028-3886.246258-82","first-page":"374","volume-title":"Ciprofloxacin-induced neurotoxicity: Evaluation of possible underlying mechanisms","author":"Ilgin","year":"2015","journal-title":"Toxicol Mech Methods"},{"key":"key-10.4103\/0028-3886.246258-83","first-page":"138","volume-title":"Association of a Tourette-like syndrome with ofloxacin","author":"Thomas","year":"1996","journal-title":"Ann Pharmacother"},{"key":"key-10.4103\/0028-3886.246258-84","first-page":"605","volume-title":"Neurotoxicity and toxicokinetics of norfloxacin in conscious rats","author":"Zhang","year":"2003","journal-title":"Acta Pharmacol Sin"},{"key":"key-10.4103\/0028-3886.246258-85","first-page":"313","volume-title":"Clarithromycin-induced neurotoxicity in adults","author":"Bandettini","year":"2011","journal-title":"J Clin Neurosci"},{"key":"key-10.4103\/0028-3886.246258-86","first-page":"206","volume-title":"Comparison of therapeutic effects of oral doxycycline and azithromycin in patients with moderate acne vulgaris: What is the role of age?","author":"Babaeinejad","year":"2011","journal-title":"J Dermatolog Treat"},{"key":"key-10.4103\/0028-3886.246258-87","first-page":"308","volume-title":"Exacerbation of pseudoparalytic myasthenia gravis following azithromycin (Zithromax)","author":"Cadisch","year":"1996","journal-title":"Schweiz Med Wochenschr"},{"key":"key-10.4103\/0028-3886.246258-88","first-page":"25","volume-title":"Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients","author":"Principi","year":"1999","journal-title":"Drug Saf"},{"key":"key-10.4103\/0028-3886.246258-89","first-page":"604","volume-title":"Clarithromycin and digoxin toxicity","author":"Trivedi","year":"1998","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/0028-3886.246258-90","first-page":"464","volume-title":"Central nervous system disturbances following clarithromycin ingestion","author":"Geiderman","year":"1999","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0028-3886.246258-91","first-page":"486","volume-title":"Delirium probably induced by clarithromycin in a patient receiving fluoxetine","author":"Pollak","year":"1995","journal-title":"Ann Pharmacother"},{"key":"key-10.4103\/0028-3886.246258-92","first-page":"297","volume-title":"Neuropsychiatric reaction induced by clarithromycin in a patient on highly active antiretroviral therapy (HAART)","author":"Prime","year":"2001","journal-title":"Sex Transm Infect"},{"key":"key-10.4103\/0028-3886.246258-93","first-page":"66","volume-title":"Acute manic psychosis induced by triple therapy for H.pylori","author":"Neff","year":"2002","journal-title":"The J Am Board Fam Pract"},{"key":"key-10.4103\/0028-3886.246258-94","first-page":"143","volume-title":"Clarithromycin-associated visual hallucinations in a patient with chronic renal failure on continuous ambulatory peritoneal dialysis","author":"Steinman","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/0028-3886.246258-95","first-page":"331","volume-title":"Clarithromycin monotherapy-induced delirium","author":"Ozsoylar","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0028-3886.246258-96","first-page":"540","volume-title":"Clarithromycin-induced delirium in a general hospital","author":"Mermelstein","year":"1998","journal-title":"Psychosomatics"},{"key":"key-10.4103\/0028-3886.246258-97","first-page":"595","volume-title":"Mania due to clarithromycin therapy in a patient who was not infected with human immunodeficiency virus","author":"Cone","year":"1996","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0028-3886.246258-98","first-page":"20","volume-title":"Hallucinations with therapeutic doses of clarithromycin","author":"Jimenez","year":"2002","journal-title":"Int J Clin Pharmacol Ther"},{"key":"key-10.4103\/0028-3886.246258-99","first-page":"2033","volume-title":"Secondary mania in older adults","author":"Brooks","year":"2005","journal-title":"Am J Psychiatry"},{"key":"key-10.4103\/0028-3886.246258-100","first-page":"1563","volume-title":"Clarithromycin-induced mania in two patients with AIDS","author":"Nightingale","year":"1995","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0028-3886.246258-101","first-page":"325","volume-title":"Case of psychosis due to prednisone-clarithromycin interaction","author":"Finkenbine","year":"1998","journal-title":"Gen Hosp Psychiatry"},{"key":"key-10.4103\/0028-3886.246258-102","first-page":"1626","volume-title":"Clarithromycin-induced mania","author":"Abouesh","year":"1998","journal-title":"Am J Psychiatry"},{"key":"key-10.4103\/0028-3886.246258-103","first-page":"579","volume-title":"Acute psychosis induced by clarithromycin in a healthy adult?","author":"Kouvelou","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"key-10.4103\/0028-3886.246258-104","first-page":"225","volume-title":"Acute delirium, probably precipitated by clarithromycin","author":"Pijlman","year":"2001","journal-title":"Ned Tijdschr Geneeskd"},{"key":"key-10.4103\/0028-3886.246258-105","first-page":"321","volume-title":"Hallucinations by administration of a standard regimen of clarithromycin","author":"Fernandez","year":"2007","journal-title":"Farm Hosp"},{"key":"key-10.4103\/0028-3886.246258-106","first-page":"70","volume-title":"Clarithromycin-induced acute psychoses in peptic ulcer disease","author":"Gomez-Gil","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key-10.4103\/0028-3886.246258-107","first-page":"415","volume-title":"Delusion of worm infestation associated with clarithromycin in a patient on peritoneal dialysis","author":"Tse","year":"2001","journal-title":"Perit Dial Int"},{"key":"key-10.4103\/0028-3886.246258-108","first-page":"119","volume-title":"Three new cases of severe affective disorders induced by clarithromycin","author":"Gomez","year":"2002","journal-title":"Med Clin"},{"key":"key-10.4103\/0028-3886.246258-109","first-page":"99","volume-title":"A case of clarithromycin-induced manic episode (antibiomania)","author":"Ortiz-Dominguez","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"key-10.4103\/0028-3886.246258-110","first-page":"e739","volume-title":"Transient psychosis in an immune-competent patient after oral trimethoprim-sulfamethoxazole administration","author":"Saidinejad","year":"2005","journal-title":"Pediatrics"},{"key":"key-10.4103\/0028-3886.246258-111","first-page":"782","volume-title":"Central nervous system Whipple's disease: Relapse during therapy with trimethoprim-sulfamethoxazole and remission with cefixime","author":"Cooper","year":"1994","journal-title":"Gastroenterology"},{"key":"key-10.4103\/0028-3886.246258-112","first-page":"530","volume-title":"A rare case of cotrimoxazole-induced eosinophilic aseptic meningitis in an HIV-infected patient","author":"Patey","year":"1998","journal-title":"Scand J Infect Dis"},{"key":"key-10.4103\/0028-3886.246258-113","first-page":"1456","volume-title":"Trimethoprim-sulfamethoxazole- induced tremor in an immunocompetent patients","author":"Patterson","year":"1999","journal-title":"Pharmacotherapy"},{"key":"key-10.4103\/0028-3886.246258-114","first-page":"448","volume-title":"Adverse reactions of nitrofurantoin, trimethoprim and sulfamethoxazole in children","author":"Karpman","year":"2004","journal-title":"J Urol"},{"key":"key-10.4103\/0028-3886.246258-115","first-page":"433","volume-title":"Early onset probable linezolid-induced encephalopathy","author":"Fletcher","year":"2010","journal-title":"J Neurology"},{"key":"key-10.4103\/0028-3886.246258-116","first-page":"1183","volume-title":"Bell's palsy associated with linezolid therapy: Case report and review of neuropathic adverse events","author":"Thai","year":"2006","journal-title":"Pharmacotherapy"},{"key":"key-10.4103\/0028-3886.246258-117","first-page":"151","volume-title":"Possibly linezolid-induced peripheral and central neurotoxicity: Report of four cases","author":"Ferry","year":"2005","journal-title":"Infection"},{"key":"key-10.4103\/0028-3886.246258-118","first-page":"1189","volume-title":"Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome","author":"Narita","year":"2007","journal-title":"Pharmacotherapy"},{"key":"key-10.4103\/0028-3886.246258-119","first-page":"1430","volume-title":"Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: Systematic review and meta-analysis","author":"Sotgiu","year":"2012","journal-title":"Eur Respir J"},{"key":"key-10.4103\/0028-3886.246258-120","first-page":"1114","volume-title":"Linezolid-induced optic neuropathy","author":"Saijo","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0028-3886.246258-121","first-page":"111","volume-title":"Linezolid-induced optic neuropathy: A mitochondrial disorder?","author":"Javaheri","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0028-3886.246258-122","first-page":"279","volume-title":"Efficacy of 2% metronidazole gel in moderate acne vulgaris","author":"Khodaeiani","year":"2012","journal-title":"Indian J Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5154","issn-type":"print"},{"key":"key-10.4103\/0028-3886.246258-123","first-page":"462","volume-title":"Painful neuropathy due to skin denervation after metronidazole-induced neurotoxicity","author":"Tan","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.4103\/0028-3886.246258-124","first-page":"372","volume-title":"Acute painful peripheral neuropathy due to metronidazole","author":"Sarma","year":"2005","journal-title":"Neurol India","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3886","issn-type":"print"},{"key":"key-10.4103\/0028-3886.246258-125","first-page":"585","volume-title":"Reversible optic neuropathy due to metronidazole","author":"McGrath","year":"2007","journal-title":"Clin Exp Ophthalmol"},{"key":"key-10.4103\/0028-3886.246258-126","first-page":"429","volume-title":"Metronidazole: Newly recognized cause of autonomic neuropathy","author":"Hobson-Webb","year":"2006","journal-title":"J Child Neurol"},{"key":"key-10.4103\/0028-3886.246258-127","first-page":"3903","volume-title":"Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosis","author":"Carroll","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0028-3886.246258-128","first-page":"e111","volume-title":"Cerebellar ataxia following prolonged use of metronidazole: Case report and literature review","author":"Patel","year":"2008","journal-title":"Int J Infect Dis"},{"key":"key-10.4103\/0028-3886.246258-129","first-page":"588","volume-title":"Reversible magnetic resonance imaging findings in metronidazole-induced encephalopathy","author":"Ahmed","year":"1995","journal-title":"Neurology"},{"key":"key-10.4103\/0028-3886.246258-130","first-page":"449","volume-title":"Polymyxins revisited","author":"Landman","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"key-10.4103\/0028-3886.246258-131","first-page":"759","volume-title":"Neurotoxic and nephrotoxic effects of colistin patients with renal disease","author":"Wolinsky","year":"1962","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0028-3886.246258-132","unstructured":"Duncan DA. Colistin toxicity. Neuromuscular and renal manifestations. Two cases treated by hemodialysis. Minn Med 1973;56:31-5."},{"key":"key-10.4103\/0028-3886.246258-133","first-page":"549","volume-title":"The Mechanism of the neuromuscular blockade by antibiotics","author":"Kubikowski","year":"1963","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"key-10.4103\/0028-3886.246258-134","first-page":"345","volume-title":"Neurotoxicity in patients treated with intravenous polymyxin B: Two case reports","author":"Weinstein","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"key-10.4103\/0028-3886.246258-135","first-page":"655","volume-title":"Nervous system effects of antituberculosis therapy","author":"Kass","year":"2010","journal-title":"CNS Drugs"},{"key":"key-10.4103\/0028-3886.246258-136","first-page":"765","volume-title":"Histopathology of experimental ethambutol intoxication","author":"Lessell","year":"1976","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0028-3886.246258-137","first-page":"408","volume-title":"The outcome of pseudotumor cerebri induced by tetracycline therapy","author":"Kesler","year":"2004","journal-title":"Acta Neurol Scand"},{"key":"key-10.4103\/0028-3886.246258-138","first-page":"39","volume-title":"Intravitreal clindamycin plus dexamethasone versus classic oral therapy in toxoplasmic retinochoroiditis: A prospective randomized clinical trial","author":"Baharivand","year":"2013","journal-title":"Int Ophthalmol"},{"key":"key-10.4103\/0028-3886.246258-139","first-page":"999","volume-title":"Topical 4% nicotinamide vs.1% clindamycin in moderate inflammatory acne vulgaris","author":"Khodaeiani","year":"2013","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0028-3886.246258-140","first-page":"221","volume-title":"Abnormal movements with the addition of clindamycin to risperidone in a girl with autism","author":"Malone","year":"2008","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"key-10.4103\/0028-3886.246258-141","first-page":"32","volume-title":"Possible ameliorative effects of antioxidants on propionic acid\/clindamycin- induced neurotoxicity in Syrian hamsters","author":"El-Ansary","year":"2013","journal-title":"Gut Pathog"},{"key":"key-10.4103\/0028-3886.246258-142","first-page":"9","volume-title":"The neurotoxic effect of clindamycin-induced gut bacterial imbalance and orally administered propionic acid on DNA damage assessed by the comet assay: Protective potency of carnosine and carnitine","author":"El-Ansary","year":"2013","journal-title":"Gut Pathog"},{"key":"key-10.4103\/0028-3886.246258-143","first-page":"474","volume-title":"Antimicrobial therapy and local toxicity of intraventricular administration of vancomycin in a neonate with ventriculitis","author":"Nava-Ocampo","year":"2006","journal-title":"Ther Drug Monit"},{"key":"key-10.4103\/0028-3886.246258-144","first-page":"142","volume-title":"Therapeutic vancomycin monitoring in children with hydrocephalus during treatment of shunt infections","author":"Bafeltowska","year":"2004","journal-title":"Surg Neurol"},{"key":"key-10.4103\/0028-3886.246258-145","first-page":"554","volume-title":"Nitrofurantoin polyneuropathy","author":"Toole","year":"1973","journal-title":"Neurology"},{"key":"key-10.4103\/0028-3886.246258-146","first-page":"163","volume-title":"Nitrofurantoin toxicity in children","author":"Coraggio","year":"1989","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.4103\/0028-3886.246258-147","first-page":"540","volume-title":"Nitrofurantoin","author":"D'Arcy","year":"1985","journal-title":"Drug Intell Clin Pharm"},{"key":"key-10.4103\/0028-3886.246258-148","first-page":"771","volume-title":"Letter: Benign intracranial hypertension associated with nitrofurantoin therapy","author":"Sharma","year":"1974","journal-title":"Br Med J"},{"key":"key-10.4103\/0028-3886.246258-149","first-page":"214","volume-title":"Dapsone and peripheral motor neuropathy","author":"Saqueton","year":"1969","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0028-3886.246258-150","first-page":"699","volume-title":"Bilateral optic neuritis caused by chloramphenicol","author":"Venegas-Francke","year":"2000","journal-title":"Rev Neurol"},{"key":"key-10.4103\/0028-3886.246258-151","first-page":"358","volume-title":"Chloramphenicol neurotoxicity","author":"Ramilo","year":"1988","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.4103\/0028-3886.246258-152","first-page":"1","volume-title":"The carbapenems: New broad spectrum beta-lactam antibiotics","author":"Moellering","year":"1989","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0028-3886.246258-153","first-page":"2043","volume-title":"The risk of seizures among the carbapenems: A meta-analysis","author":"Cannon","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0028-3886.246258-154","first-page":"310","volume-title":"Penicillin neurotoxicity","author":"Lerner","year":"1967","journal-title":"Ann N Y Acad Sci"},{"key":"key-10.4103\/0028-3886.246258-155","first-page":"361","volume-title":"Neurologic toxicity associated with high-dose metronidazole therapy","author":"Frytak","year":"1978","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/0028-3886.246258-156","first-page":"479","volume-title":"Isoniazid overdose: A case series, literature review and survey of antidote availability","author":"Maw","year":"2003","journal-title":"Clin Drug Invest"},{"key":"key-10.4103\/0028-3886.246258-157","first-page":"123","volume-title":"Potential interactions of the extended-spectrum fluoroquinolones with the CNS","author":"Lode","year":"1999","journal-title":"Drug Saf"},{"key":"key-10.4103\/0028-3886.246258-158","first-page":"657","volume-title":"Safety profile of meropenem: An updated review of over 6,000 patients treated with meropenem","author":"Linden","year":"2007","journal-title":"Drug Saf"},{"key":"key-10.4103\/0028-3886.246258-159","first-page":"92S","volume-title":"Safety of intravenous ciprofloxacin.A review","author":"Arcieri","year":"1989","journal-title":"Am J Med"},{"key":"key-10.4103\/0028-3886.246258-160","first-page":"38","volume-title":"Latest industry information on the safety profile of levofloxacin in Japan","author":"Yagawa","year":"2001","journal-title":"Chemotherapy"},{"key":"key-10.4103\/0028-3886.246258-161","first-page":"102","volume-title":"Ciprofloxacin-induced toxic optic neuropathy","author":"Samarakoon","year":"2007","journal-title":"Clin Exp Ophthalmol"},{"key":"key-10.4103\/0028-3886.246258-162","first-page":"124","volume-title":"Oral levofloxacin-induced optic neuritis progressing in loss of vision","author":"Das","year":"2012","journal-title":"Ther Drug Monit"},{"key":"key-10.4103\/0028-3886.246258-163","first-page":"1417","volume-title":"Chloramphenicol optic neuropathy","author":"Godel","year":"1980","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0028-3886.246258-164","first-page":"137","volume-title":"Toxic optic neuropathy","author":"Sharma","year":"2011","journal-title":"Indian J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-4738","issn-type":"print"},{"key":"key-10.4103\/0028-3886.246258-165","first-page":"69","volume-title":"Update on medication-induced peripheral neuropathy","author":"Weimer","year":"2009","journal-title":"Curr Neurol Neurosci Rep"},{"key":"key-10.4103\/0028-3886.246258-166","first-page":"729","volume-title":"Drug-induced neuropathies","author":"Manji","year":"2013","journal-title":"Hand Clin Neurol"},{"key":"key-10.4103\/0028-3886.246258-167","first-page":"204","volume-title":"Medication and toxin-induced peripheral neuropathy","author":"Pratt","year":"2005","journal-title":"Semin Neurol"},{"key":"key-10.4103\/0028-3886.246258-168","first-page":"1111","volume-title":"Antibiotics in myasthenia gravis","author":"Hokkanen","year":"1964","journal-title":"Br Med J"},{"key":"key-10.4103\/0028-3886.246258-169","first-page":"346","volume-title":"The aggravating effect of some antibiotics on the neuromuscular blockade in myasthenia gravis","author":"Hokkanen","year":"1964","journal-title":"Acta Neurol Scand"},{"key":"key-10.4103\/0028-3886.246258-170","first-page":"839","volume-title":"Fluoroquinolone-associated myasthenia gravis exacerbation: Evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review","author":"Jones","year":"2011","journal-title":"Drug Saf"},{"key":"key-10.4103\/0028-3886.246258-171","first-page":"352","volume-title":"Azithromycin-induced myasthenic crisis: Reversibility with calcium gluconate","author":"Pradhan","year":"2009","journal-title":"Neurol India","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3886","issn-type":"print"},{"key":"key-10.4103\/0028-3886.246258-172","first-page":"175","volume-title":"A clarithromycin-induced myasthenic syndrome","author":"Pijpers","year":"1996","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0028-3886.246258-173","first-page":"155","volume-title":"Aggravation of myasthenia gravis by erythromycin","author":"Absher","year":"1991","journal-title":"J Pediatr"},{"key":"key-10.4103\/0028-3886.246258-174","first-page":"577","volume-title":"Aggravation of myasthenia gravis by erythromycin","author":"May","year":"1990","journal-title":"Ann Neurol"},{"key":"key-10.4103\/0028-3886.246258-175","first-page":"399","volume-title":"Drugs and myasthenia gravis.An update","author":"Wittbrodt","year":"1997","journal-title":"Arch Intern Med"},{"key":"key-10.4103\/0028-3886.246258-176","first-page":"409","volume-title":"Drug therapy: Disorders of neuromuscular transmission caused by drugs","author":"Argov","year":"1979","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0028-3886.246258-177","first-page":"105","volume-title":"Therapeutically relevant concentrations of neomycin selectively inhibit P-type Ca2+ channels in rat striatum","author":"Dobrev","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"key-10.4103\/0028-3886.246258-178","first-page":"502","volume-title":"Calcium-sensing receptor: A high-affinity presynaptic target for aminoglycoside-induced weakness","author":"Harnett","year":"2009","journal-title":"Neuropharmacology"},{"key":"key-10.4103\/0028-3886.246258-179","first-page":"179","volume-title":"Effects of the quinoline derivatives quinine, quinidine, and chloroquine on neuromuscular transmission","author":"Sieb","year":"1996","journal-title":"Brain Res"},{"key":"key-10.4103\/0028-3886.246258-180","first-page":"804","volume-title":"Fluoroquinolone antibiotics block neuromuscular transmission","author":"Sieb","year":"1998","journal-title":"Neurology"},{"key":"key-10.4103\/0028-3886.246258-181","doi-asserted-by":"crossref","unstructured":"Bertrand D, Bertrand S, Neveu E, Fernandes P. Molecular characterization of off-target activities of telithromycin: A potential role for nicotinic acetylcholine receptors. Antimicrob Agents Chemother 2010;54:5399-402.","DOI":"10.1128\/AAC.00840-10"}],"container-title":["Neurology India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:43:25Z","timestamp":1786715005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.246258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":181,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"alternative-id":["246258"],"URL":"https:\/\/doi.org\/10.4103\/0028-3886.246258","relation":{},"ISSN":["0028-3886"],"issn-type":[{"value":"0028-3886","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}